Presented:

NeoGenomics Schedules its Q3 2013 Earnings Release for October 23, 2013

Read Now

Presented:

NeoGenomics Revises Upward its Quarter 3 2013 Guidance

Read Now

Presented:

NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter

Read Now

Presented:

NeoGenomics Schedules its Q1 2013 Earnings Release for April 25, 2013

Read Now

Presented:

NeoGenomics Announces Pricing of $9.5 Million Public Offering

Read Now

Presented:

NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012

Read Now

Presented:

NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013

Read Now

Presented:

NeoGenomics Validates and Launches NeoSITE™ Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer

Read Now